Details
Stereochemistry | RACEMIC |
Molecular Formula | C9H10N2O |
Molecular Weight | 162.1885 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NCC(O1)C2=CC=CC=C2
InChI
InChIKey=SYAKTDIEAPMBAL-UHFFFAOYSA-N
InChI=1S/C9H10N2O/c10-9-11-6-8(12-9)7-4-2-1-3-5-7/h1-5,8H,6H2,(H2,10,11)
Molecular Formula | C9H10N2O |
Molecular Weight | 162.1885 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Aminorex is an anorectic stimulant drug. Aminorex inhibits norepinephrine and dopamine transporters with IC50 of 0.33 and 0.85 uM. It was briefly available as an appetite suppressant in the 1960s in Switzerland, Germany, and Austria, but was found to cause pronounced vasoconstriction in the pulmonary vasculature, and was withdrawn from the market in 1972 due to several cases of fatal and life-threatening pulmonary hypertension. In the USA aminorex is an illegal schedule I drug.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
[Development of pulmonary hypertension and multi-valvular damage caused by appetite depressants]. | 1998 Dec 1 |
|
Two different drug-induced pulmonary complications in a patient suffering from rheumatoid arthritis. | 1998 May |
|
[Obesity: principles of drug therapy]. | 2000 Aug |
|
Anorectic drugs and pulmonary hypertension from the bedside to the bench. | 2001 Apr |
|
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. | 2001 Jan |
|
[Pulmonary hypertension and obesity]. | 2002 Apr |
|
Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine. | 2002 Jun 7 |
|
A century of pulmonary hemodynamics. | 2004 Jul 15 |
|
Pulmonary hypertension: therapeutic targets within the serotonin system. | 2008 Oct |
|
The formation of aminorex in racehorses following levamisole administration. A quantitative and chiral analysis following synthetic aminorex or levamisole administration vs. aminorex-positive samples from the field: a preliminary report. | 2009 Apr |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:01:26 GMT 2023
by
admin
on
Fri Dec 15 16:01:26 GMT 2023
|
Record UNII |
2SH16612I9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
1585
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
||
|
NCI_THESAURUS |
C29728
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL106258
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
AMINOREX
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
1652
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
2207-50-3
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
SUB05448MIG
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
175
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
m1742
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | Merck Index | ||
|
16630
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
DB01490
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
DTXSID00862867
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
C72180
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
2SH16612I9
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
100000087229
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
D000635
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
7596
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY | |||
|
66952
Created by
admin on Fri Dec 15 16:01:26 GMT 2023 , Edited by admin on Fri Dec 15 16:01:26 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |